Nursing concerns about the integration of closed-system transfer devices (CSTDs) into their workflow may have been the foremost consideration at Doctors Hospital at Renaissance’s when they decided on a CSTD vendor, but the implementation team evaluated other factors as well, according to Ron Ozuna, PharmD, BCPS.
“The company rep was key in helping make the switch,” said Dr. Ozuna, who is clinical coordinator of Pharmacy Services at the hospital in Edinburg, Texas. His team ultimately chose the Texium closed male lure and SmartSite needle-free valve products (CareFusion Corporation). “We had reps from several companies come in, but the CareFusion rep was most effective in educating and assisting staff with the closed system.”
Dr. Ozuna said the CareFusion representative helped obtain nursing buy-in to the very idea of a closed system by emphasizing the added safety of CSTDs and promptly addressing staff questions, with the goal of minimizing workflow disruptions.
Other institutions have documented rigorous CSTD evaluations, including wipe studies to determine how much a CSTD reduces surface contamination (see Pharmacy Practice News 2009;36:08). However, Dr. Ozuna said his team’s evaluation process was “relatively informal. We did conduct some UV [ultraviolet] light examinations to identify spills and leaks, and we looked to published literature showing that a closed system reduces exposure, but we did not look at product-specific studies. It was mostly a matter of trying out the different products and feeling out how comfortable we were with these products.”
Compatibility was also a consideration that led to choosing CareFusion as their vendor, he noted.
“We already had CareFusion elements in place, including Alaris pumps, so this was a natural fit and staff already felt comfortable with the pharmacy and intravenous line products,” Dr. Ozuna said.
Finally—but not least among the evaluation considerations—there was the cost variable, Dr. Ozuna noted, adding, “CareFusion’s system was the most affordable.”